ArticleTrials2020

Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial.

Jonas Kuon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.